Biotechnology Stocks
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3605 |  BCYC Bicycle Therapeutics plc - American Depositary Shares | 4.29 USD | -2.05% | +1.66% | +4.13% | -42.95% | 216.10 M USD | ||
| 3607 |  NERV Minerva Neurosciences, Inc - Common Stock | 4.61 USD | -3.35% | -14.79% | -1.28% | +174.40% | 214.77 M USD | ||
| 3624 |  KRRO Korro Bio, Inc. - Common Stock | 14.42 USD | -0.48% | +5.26% | +33.77% | -62.93% | 207.97 M USD | ||
| 3625 |  SLGL Sol-Gel Technologies Ltd. - Ordinary Shares | 74.35 USD | -3.23% | +3.54% | -8.19% | +931.21% | 207.15 M USD | ||
| 3632 |  ARCT Arcturus Therapeutics Holdings Inc. - Common Stock | 7.24 USD | -4.74% | +4.93% | -0.55% | -48.29% | 205.78 M USD | ||
| 3635 |  ALEC Alector, Inc. - Common Stock | 1.84 USD | -4.66% | -7.54% | +12.20% | +21.05% | 204.29 M USD | ||
| 3638 |  IMUX Immunic, Inc. - Common Stock | 14.86 USD | -3.26% | -0.54% | +19.84% | +1690.36% | 202.42 M USD | ||
| 3639 |  CRBU Caribou Biosciences, Inc. - Common Stock | 2.03 USD | +5.73% | +16.00% | +8.56% | +24.54% | 201.34 M USD | ||
| 3651 |  TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 12.47 USD | -1.89% | +0.89% | +6.40% | -16.92% | 198.78 M USD | ||
| 3655 |  QSI Quantum-Si Incorporated - Class A Common Stock | 0.91 USD | -1.09% | -3.19% | -14.15% | -50.00% | 198.16 M USD | ||
| 3664 |  ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 2.71 USD | +5.45% | +5.04% | +23.18% | +120.33% | 195.74 M USD | ||
| 3665 |  TNYA Tenaya Therapeutics, Inc. - Common Stock | 0.90 USD | -2.17% | +21.62% | +28.57% | +38.46% | 195.30 M USD | ||
| 3668 |  OTLK Outlook Therapeutics, Inc. - Common Stock | 1.61 USD | +10.27% | +7.33% | +123.61% | +292.68% | 194.59 M USD | ||
| 3670 |  PLX Protalix BioTherapeutics, Inc. Common Stock | 2.41 USD | +1.69% | +3.88% | +22.96% | -17.47% | 194.18 M USD | ||
| 3674 |  WHWK Whitehawk Therapeutics, Inc. - Common Stock | 3.92 USD | -5.54% | -12.89% | -3.92% | +30.23% | 193.85 M USD | ||
| 3687 |  EQ Equillium, Inc. - Common Stock | 2.97 USD | +3.12% | 0.00% | +6.07% | +858.06% | 187.78 M USD | ||
| 3689 |  LENZ LENZ Therapeutics, Inc. - Common Stock | 5.96 USD | +1.02% | +4.75% | -12.09% | -81.66% | 186.87 M USD | ||
| 3690 |  MDWD MediWound Ltd. - Ordinary Shares | 14.55 USD | -2.61% | -2.02% | +2.46% | -21.52% | 186.75 M USD | ||
| 3693 |  ADAG Adagene Inc - ADS, each representing 1.25 | 3.93 USD | 0.00% | -16.38% | +19.82% | +106.84% | 186.23 M USD | ||
| 3722 |  ACOG Alpha Cognition Inc. - Common Stock | 8.15 USD | +0.62% | +4.62% | +33.61% | -25.50% | 177.46 M USD |
Notizie Biotechnology Stocks
TD Cowen conferma il Buy su Prime Medicine dopo la vittoria nell’arbitrato
BofA conferma il rating su Beam Therapeutics dopo il lodo arbitrale
Perché il titolo Beam Therapeutics sta scendendo oggi?
Perché il titolo Prime Medicine è in forte rialzo oggi?
Il titolo di Incyte raggiunge il massimo di 52 settimane a 118,77 USD
Il titolo di Prime Medicine sale dopo la vittoria nell’arbitrato contro Beam
Nurix Therapeutics: focus sull’impatto dell’accordo con Roche
Gainers Biotechnology Stocks
 TVRD Tvardi Therapeutics, Inc. - Common Stock | 4.76 | +53.55% |
 APLMW Apollomics Inc. - Warrant | 0.0161 | +34.17% |
 ELTX Elicio Therapeutics, Inc. - Common Stock | 3.51 | +25.36% |
 PRME Prime Medicine, Inc. - Common Stock | 4.76 | +19.30% |
 SILO Silo Pharma Inc -, effectuated 1:50 R/S on 9/15 | 6.50 | +14.84% |
 VANI Vivani Medical, Inc. - Common Stock | 1.55 | +14.81% |
 CBUS Cibus, Inc. - Class A Common Stock | 1.70 | +13.33% |
 CINGW Cingulate Inc. - Warrants | 0.0232 | +11.00% |
Losers Biotechnology Stocks
 CMMB Chemomab Therapeutics Ltd - American Depositary Shares | 1.85 | -33.21% |
 BTAI BioXcel Therapeutics, Inc. - Common Stock | 0.82 | -21.15% |
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0139 | -17.26% |
 JUNS Jupiter Neurosciences, Inc. - Common Stock | 0.19 | -13.64% |
 ACTU Actuate Therapeutics, Inc. - Common stock | 1.32 | -13.16% |
 LTRN Lantern Pharma Inc. - Common Stock | 3.11 | -12.89% |
 ONCO Onconetix, Inc. - Common Stock | 0.94 | -12.15% |
 MCRB Seres Therapeutics, Inc. - Common Stock | 7.18 | -11.79% |